Target intelligence / Profile preview

Defensin beta 130D pseudogene (DEFB130D)

Target
DEFB130D
Molecular classification
Other (pseudogene; not an enzyme, receptor, transporter, or typical molecular target)
01

Overview

Defensin beta 130D (DEFB130D) is a pseudogene in the beta-defensin family, indicated by the "D" suffix that typically denotes non-functional gene copies in gene nomenclature[2]. Unlike functional defensin genes such as DEFB130, DEFB130D does not encode an active antimicrobial peptide and does not participate in immune responses, host defense, or serve as a therapeutic target. If the interest is in an immune effector molecule, the functional gene is Defensin beta 130 (DEFB130), not DEFB130D.\n\nFor reference, the defensin beta family generally consists of small, cationic peptides involved in the innate immune system, with antimicrobial and immunomodulatory activities[1][3][5]. However, this does not apply to DEFB130D, which is genomically present but non-functional. \n\nThe use of DEFB130D as a drug target would be incorrect; research, functional, and therapeutic literature focus on functional beta-defensin genes and their protein products, not pseudogenes.

Other names
Beta-defensin 130 pseudogeneDEFB130D

Beyond the preview

Go deeper on Defensin beta 130D pseudogene (DEFB130D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Defensin beta 130D pseudogene (DEFB130D).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call